Trxade Group Inc. (NASDAQ: MEDS) Reports Revenue Growth Amid Buildup to Multi-Platform Telehealth Integration
Trxade Group Inc. is an expanding healthcare tech platform builder that aims to assist small, community-based pharmaceutical businesses and the patients who comprise their customers through drug pricing and delivery operations as well as telemedicine consultations Trxade Group recently announced its year-end financial statement for 2019, noting revenues had grown nearly double over the previous year, from $3.83 million to $7.43 million The company is celebrating a decade in operation with four platforms that are integrated synergistically to serve the needs of rural and neighborhood-centric health businesses on a subscription basis Trxade’s telehealth services enable patients to access licensed medical…